Babson Diagnostics Recognized for Achieving Highest Standards for Laboratory Medicine

Babson awarded accreditation for meeting the highest standards of quality and patient safety in lab practices

Austin, Texas — Babson Diagnostics, a science-first health care technology company, today announced its laboratory has been awarded accreditation by the College of American Pathologists (CAP) based on the results of a recent site inspection.

CAP is a leading health care accreditation agency, known for its comprehensive and scientifically rigorous standards. Babson’s compliance means the company is meeting the highest standards of quality and patient safety in its laboratory practices.

Babson’s lab in Austin first received CAP accreditation in 2020. In the renewal application, Babson for the first time demonstrated proficiency for its proprietary testing techniques, a critical innovation in its unique end-to-end technological ecosystem that reimagines blood testing for today’s consumer. Babson built its high-efficiency lab to run broad blood panels using one-tenth the sample volume of traditional blood tests. The company has developed miniaturized assays to optimize each microsample.

“We thank the Accreditation Committee of the College of American Pathologists for its thorough review,” said James Jacobson, Ph.D., vice president of clinical affairs at Babson. “Receiving accreditation reflects our commitment to a rigorous scientific evaluation of our innovative analysis technologies before commercialization of the Babson blood-testing system.”

The U.S. federal government recognizes the CAP Laboratory Accreditation Program, begun in the early 1960s, as being equal to or more stringent than the government's own inspection program.

During the CAP accreditation process, designed to ensure the highest standard of care for all laboratory patients, inspectors examine the laboratory's records and quality control of procedures for the preceding two years. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management.

“On our journey to make routine blood testing easier, more accessible, and less invasive, we are innovating with integrity,” said David Stein, Ph.D., Babson's chief executive officer. “Achieving accreditation is another step in our plan to show that our unique ecosystem meets high scientific standards and produces quality diagnostic results that patients and providers can rely on.”